Share class: Viyash Scientific Limited

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 249,889,745 117,774,492 ( 47.13 %) 0 47.13 %

Major shareholders: Viyash Scientific Limited

NameEquities%Valuation
The Carlyle Group LP (Global Private Equity)
61.34 %
267,840,334 61.34 % 626 M ₹
quant Money Managers Ltd.
5.675 %
24,777,412 5.675 % 58 M ₹
Ashoka Whiteoak Capital Pte Ltd.
0.8461 %
3,694,299 0.8461 % 9 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.2505 %
1,093,865 0.2505 % 3 M ₹
Motilal Oswal Asset Management Co. Ltd.
0.113 %
493,255 0.113 % 1 M ₹
Government of India
0.009721 %
42,445 0.009721 % 99 212 ₹
Groww Asset Management Ltd.
0.000597 %
2,606 0.000597 % 6 091 ₹
Bandhan AMC Ltd.
0.000404 %
1,766 0.000404 % 4 128 ₹
Angel One Asset Management Co. Ltd.
0.000171 %
747 0.000171 % 1 746 ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
0.000084 %
367 0.000084 % 858 ₹

Breakdown by shareholder type

Institutional68.23%
Governments0.01%
Unknown31.76%

Based on 1000 largest holdings

Geographical origin of shareholders

United States
61.34%
India
6.05%
Singapore
0.85%

Based on 1000 largest holdings

Logo Viyash Scientific Limited
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. The Company’s subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
Employees
1,244
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW